Brain Tumour Conference 2020
CORONAVIRUS INFORMATION: CANCER RESEARCH UK EVENTS
Last updated 13 March, 2020
Important information regarding your registration at the Brain Tumour Conference 2020
Cancer Research UK have been closely monitoring developments relating to the coronavirus (COVID-19) outbreak and reviewing guidance from government bodies. After careful consideration we have taken the decision not to go ahead as planned, with the Brain Tumour Conference scheduled for 12-14 May 2020.
With the number of attendees, including those travelling internationally, and given that many of you work with vulnerable communities, we agreed that safeguarding your health and safety, and the health and safety of those you work with, is our priority. With global restrictions on international travel continuing to grow, it would not be possible to hold the event in its current format without impacting on the quality of the sessions.
Please review our cancellation policy below. If you have any questions please email firstname.lastname@example.org
Important cancellation information
All cancellations must be made in writing to email@example.com. We do not accept telephone cancellations.
All registrants are eligible for a full refund of their ticket. If we do not receive a cancellation email, your booking will automatically be transferred to the rescheduled date. If you are unable to attend the rescheduled meeting, please email firstname.lastname@example.org to request a full refund.
Cancer Research UK are not liable for any travel or accommodation costs relating to attendee bookings.
Poster and proffered talks
Once a new date for the conference has been confirmed, we ask you to resubmit your abstract for consideration.
We are pleased to announce that Cancer Research UK will hold the 2nd international Brain Tumour Conference together with Simona Parrinello at University College London, Michelle Monje-Deisseroth at Stanford University and Richard Gilbertson at Cancer Research UK Cambridge Centre, University of Cambridge.
The conference will unite the brightest minds in cancer research to discuss and debate some of the greatest issues in the field. Our multidisciplinary programme combines expertise from across the breadth of brain tumour research, together with insights from allied disciplines, to spark new opportunities for collaborative research.
Although survival rates for most cancers have shown an encouraging upward trend, the fearsome complexity of the brain, and the plethora of different disease subtypes, has left brain tumour survival languishing at the bottom of the table.
Our intention is to provide a stimulating environment where scientists from across the research pipeline can showcase new discoveries, spark new collaborations, and create the synergy needed to accelerate progress for patients.
Submit your abstract by Friday 21 February
All attendees are eligible to submit a poster abstract. We're also giving up-and-coming postdocs and students the opportunity to showcase their work as part of our Future Leaders session.
Research opportunities in brain tumours
Brain tumour survival remains low, and has changed little in over a generation. That's why we've made brain tumours a strategic priority as one of our four "cancers of unmet need".
We're boosting our investment into brain tumours, and we have a number of opportunities to help you develop your brain tumour research or to apply your skills to these cancers for the first time.